
Alert: Rating Upgrade (4/8/24)-Xenon Pharmaceuticals Inc (NASDAQ: XENE).
Stock Rating Upgrade The Value Trend Rating for Xenon Pharmaceuticals Inc (NASDAQ: XENE) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]